Span Divergent — 360° view

Span Divergent, a company in the Pharmaceuticals industry, reported revenue of ₹5.41 crore and a net loss of ₹0.76 crore for the September 2026 quarter.

Span Divergent (BSE: SDL) closed at ₹27.00 on 18 Nov 2026, down 11.7% over the past year. Its market capitalisation is ₹20 crore.

Share price
₹27.00 (18 Nov 2026)
Market cap
₹20 Cr (18 Nov 2026)
Revenue
₹5 Cr (September 2026 quarter)
Net profit
₹-1 Cr (September 2026 quarter)
ROCE
-34.1% (FY26)
ROE
-46.3% (FY26)
Book value
₹18.1 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹51.49 / ₹20.52 (18 Nov 2026)
1-year return
-11.7% (to 18 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: SDL

Incorporated in 1972, Span Divergent Ltd deals in different businesses through various subsidiaries.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.